In the News
Ryan Majerus discusses U.S. restrictions on Chinese biotech investments with MLex
October 30, 2026
| MLex
Featured Lawyers:
Ryan Majerus
Partner

Ryan Majerus comments on the proposed U.S. restrictions on investments in Chinese biotechnology.

Third-Party Coverage:
US pharma’s Chinese biotech deals face uncertainty under Treasury proposal

Explore King & Spalding
a ship in a port
Capabilities
International Trade